Jeffrey Humphrey

2020

In 2020, Jeffrey Humphrey earned a total compensation of $3.2M as Chief Medical Officer at CONSTELLATION PHARMACEUTICALS.

Compensation breakdown

Bonus$25,000
Non-Equity Incentive Plan$81,000
Option Awards$2,708,209
Salary$225,000
Other$131,253
Total$3,170,462

Humphrey received $2.7M in option awards, accounting for 85% of the total pay in 2020.

Humphrey also received $25K in bonus, $81K in non-equity incentive plan, $225K in salary and $131.3K in other compensation.

Rankings

In 2020, Jeffrey Humphrey's compensation ranked 3,669th out of 13,090 executives tracked by ExecPay. In other words, Humphrey earned more than 72.0% of executives.

ClassificationRankingPercentile
All
3,669
out of 13,090
72nd
Division
Manufacturing
1,443
out of 5,621
74th
Major group
Chemicals And Allied Products
544
out of 2,254
76th
Industry group
Drugs
471
out of 1,954
76th
Industry
Pharmaceutical Preparations
356
out of 1,459
76th
Source: SEC filing on April 23, 2021.

Humphrey's colleagues

We found four more compensation records of executives who worked with Jeffrey Humphrey at CONSTELLATION PHARMACEUTICALS in 2020.

2020

Jigar Raythatha

CONSTELLATION PHARMACEUTICALS

Chief Executive Officer

2020

Emma Reeve

CONSTELLATION PHARMACEUTICALS

Chief Financial Officer

2020

Patrick Trojer

CONSTELLATION PHARMACEUTICALS

Chief Scientific Officer

2020

Karen Valentine

CONSTELLATION PHARMACEUTICALS

Chief Legal Officer

News

In-depth

You may also like